Skip to main content
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1995 Mar;162(3):272–273.

Screening for prostate cancer today.

J N Kabalin
PMCID: PMC1022725  PMID: 7536994

Full text

PDF
272

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Catalona W. J., Richie J. P., Ahmann F. R., Hudson M. A., Scardino P. T., Flanigan R. C., deKernion J. B., Ratliff T. L., Kavoussi L. R., Dalkin B. L. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol. 1994 May;151(5):1283–1290. doi: 10.1016/s0022-5347(17)35233-3. [DOI] [PubMed] [Google Scholar]
  2. Catalona W. J., Smith D. S., Ratliff T. L., Basler J. W. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA. 1993 Aug 25;270(8):948–954. [PubMed] [Google Scholar]
  3. Cher M. L., Carroll P. R. Screening for prostate cancer. West J Med. 1995 Mar;162(3):235–242. [PMC free article] [PubMed] [Google Scholar]
  4. Chodak G. W. Questioning the value of screening for prostate cancer in asymptomatic men. Urology. 1993 Aug;42(2):116–118. doi: 10.1016/0090-4295(93)90633-l. [DOI] [PubMed] [Google Scholar]
  5. Gann P. H., Hennekens C. H., Stampfer M. J. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA. 1995 Jan 25;273(4):289–294. [PubMed] [Google Scholar]
  6. Krahn M. D., Mahoney J. E., Eckman M. H., Trachtenberg J., Pauker S. G., Detsky A. S. Screening for prostate cancer. A decision analytic view. JAMA. 1994 Sep 14;272(10):773–780. [PubMed] [Google Scholar]
  7. Labrie F., Dupont A., Suburu R., Cusan L., Tremblay M., Gomez J. L., Emond J. Serum prostate specific antigen as pre-screening test for prostate cancer. J Urol. 1992 Mar;147(3 Pt 2):846–852. doi: 10.1016/s0022-5347(17)37402-5. [DOI] [PubMed] [Google Scholar]
  8. Mettlin C., Jones G., Averette H., Gusberg S. B., Murphy G. P. Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers. CA Cancer J Clin. 1993 Jan-Feb;43(1):42–46. doi: 10.3322/canjclin.43.1.42. [DOI] [PubMed] [Google Scholar]
  9. Oesterling J. E., Cooner W. H., Jacobsen S. J., Guess H. A., Lieber M. M. Influence of patient age on the serum PSA concentration. An important clinical observation. Urol Clin North Am. 1993 Nov;20(4):671–680. [PubMed] [Google Scholar]
  10. Schmid H. P., McNeal J. E., Stamey T. A. Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume. Cancer. 1993 Mar 15;71(6):2031–2040. doi: 10.1002/1097-0142(19930315)71:6<2031::aid-cncr2820710618>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  11. Terris M. K., Haney D. J., Johnstone I. M., McNeal J. E., Stamey T. A. Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies. Urology. 1995 Jan;45(1):75–80. doi: 10.1016/s0090-4295(95)96858-x. [DOI] [PubMed] [Google Scholar]
  12. Wingo P. A., Tong T., Bolden S. Cancer statistics, 1995. CA Cancer J Clin. 1995 Jan-Feb;45(1):8–30. doi: 10.3322/canjclin.45.1.8. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES